Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Study to Determine Whether Use of Rhopressa™ Can Ameliorate Corneal Edema Associated With Fuchs Dystrophy

NCT04051463 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.

NCT NCT04051463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04051463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Study to Determine Whether Use of Rhopressa™ Can Ameliorate Corneal Edema Associated With Fuchs Dystrophy
Lead sponsor
Price Vision Group
Phase
Phase 2/3
Overall status
Completed
Start date
August 5, 2019
Completion date
July 1, 2020
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fuchs endothelial dystrophy